Navigation Links
Micromet Expands Committed Equity Financing Facility to $75 Million
Date:12/2/2008

securities, nor shall there be any sale of these securities in any state which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state.

About Micromet, Inc.

Micromet, Inc. (www.micromet-inc.com) is a biopharmaceutical company with offices in Bethesda, Maryland and Munich, Germany. The Company is developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases. The Company uses its proprietary BiTE(R) antibody platform to create a new class of antibodies that specifically activate T cells from the patient's own immune system to eliminate cancer cells or other disease-related cells. Four of the Company's antibodies are currently in clinical trials, with the remainder of its product pipeline in preclinical development. The Company's lead program is a BiTE antibody known as blinatumomab, or MT103. It is in a phase 2 clinical trial for the treatment of patients with acute lymphoblastic leukemia and a phase 1 clinical trial for the treatment of patients with non-Hodgkin's lymphoma. Micromet is developing blinatumomab in collaboration with MedImmune, a subsidiary of AstraZeneca plc. Micromet's second BiTE antibody in clinical development is MT110, which targets the epithelial cell adhesion molecule (EpCAM). The Company owns all rights to MT 110, which is currently in a phase 1 clinical trial for the treatment of patients with solid tumors. The Company's third clinical stage antibody is adecatumumab, also known as MT201, a conventional human monoclonal antibody that targets EpCAM-expressing solid tumors. Micromet is developing adecatumumab in collaboration with Merck Serono in a phase 1b clinical trial evaluating adecatumumab in combination with docetaxel for the treatment of patients with metastatic breast cancer. Micromet has licensed a fourth c
'/>"/>

SOURCE Micromet, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Micromet Announces Changes in Management Team
2. Micromet Announces the Publication of BiTE Antibody Review in Drugs of the Future
3. Micromet Announces Presentation of Five Posters Related to Its Proprietary BiTE Antibody Platform at Annual Meeting of American Association for Cancer Research
4. Micromet Demonstrates That the Antibodies in Commercial Products Herceptin, Erbitux, Vectibix and Xolair Can Be Converted Into Highly Potent, T Cell- Engaging BiTE Antibodies
5. Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma
6. Micromet Shows Feasibility of Subcutaneous Delivery of BiTE Antibody in Preclinical Primate Study
7. Micromet Enrolls First Patient in a Phase 1 Clinical Trial with MT110, the First BiTE Antibody for Treatment of Solid Tumors
8. Micromet to Present Clinical Update for BiTE Antibody MT103/MEDI-538 at the International Conference on Malignant Lymphomas
9. Micromets BiTE Antibody Blinatumomab (MT103/MEDI-538) Demonstrates Durable Responses in Patients with Relapsed Non-Hodgkins Lymphoma
10. Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia
11. Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/27/2014)... , 27 de octubre de 2014 /PRNewswire/ ... menudo conocida como ardor de estómago, es un ... mundo. [1] La elección de alimentos [2] ... un impacto en los síntomas de la GERD. ... ayudar a las personas a gestionar los síntomas ...
(Date:10/27/2014)... -- In the last few weeks, Ebola has gone from a localized ... a worldwide crisis when a traveler to United States ... nurses were infected. While much of the cable news ... technology, such as electronic health records (EHRs), to help find, combat, ... Healthcare Editor Alison Diana fills in those gaps by ...
(Date:10/27/2014)... Mass. , Oct. 27, 2014  OMNIlife science™, ... billion global hip and knee replacement device market, announced it ... replacement technology at the American Association of Hip and ... Dallas Hotel in Dallas, Texas ... Bronze corporate partner of the organization. ...
Breaking Medicine Technology:Trate los síntomas del reflujo gracias a la Food4GERD App 2Trate los síntomas del reflujo gracias a la Food4GERD App 3Trate los síntomas del reflujo gracias a la Food4GERD App 4EHRs in the Age of Ebola: Discuss on InformationWeek 2EHRs in the Age of Ebola: Discuss on InformationWeek 3OMNIlife science to Exhibit at American Association of Hip and Knee Surgeons 24th Annual Meeting in Dallas November 6-9 2OMNIlife science to Exhibit at American Association of Hip and Knee Surgeons 24th Annual Meeting in Dallas November 6-9 3
... Texas, Nov. 18, 2010 OCuSOFT, Inc., an ... to announce that ZYTAZE™ is now available in ... but are not limited to: Walgreens, CVS, Wal-Mart, ... In an early pilot study, ZYTAZE™ demonstrated marked ...
... FORD, Pa., Nov. 18, 2010 Endo Pharmaceuticals Holdings ... it priced $400 million aggregate principal amount of 7.00% ... of 99.10 percent in connection with its previously announced ... of the Company and will be guaranteed by certain ...
Cached Medicine Technology:Endo Pharmaceuticals Holdings Inc. Announces Pricing of Private Offering of Senior Notes 2
(Date:10/30/2014)... HealthDay Reporter WEDNESDAY, Oct. 29, 2014 ... of three West African nations ravaged by the disease -- ... Dr. Bruce Aylward, WHO,s assistant director general, said there,s been ... no increase in laboratory-confirmed cases. He said he was cautiously ... be making some progress, The New York Times ...
(Date:10/30/2014)... October 30, 2014 Global prebiotics market ... according to a new study by Grand View Research, ... demand for sugar and fat free products owing to ... demand for prebiotics over the forecast period. , View ... , Food & beverage was the largest application segment ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 The annual ... (NAMS) came to a close on Saturday, October 18th, ... the Society’s inception in 1989. NAMS is North America’s ... quality of life of all women during midlife and ... With over 2,000 physicians and thought leaders from fields ...
(Date:10/30/2014)... who used stem cells to create miniature human stomachs ... new way to learn more about the development and ... pluripotent stem cells -- which can become any type ... functional miniature stomachs, to study infection by H. ... stomach cancer. The miniature stomachs offer many research ...
(Date:10/30/2014)... a low-carb, high-fat diet could help control epilepsy that ... A review of five studies found that a ... like bacon, eggs, heavy cream, butter, fish and green ... doesn,t improve with medication. "We need new treatments ... seizures are not stopped by medications," study co-author Dr. ...
Breaking Medicine News(10 mins):Health News:Ebola Outbreak in Liberia May Be Slowing: WHO 2Health News:Ebola Outbreak in Liberia May Be Slowing: WHO 3Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 2Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 3Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 4Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 5Health News:Highlights from The North American Menopause Society 25th Annual Meeting 2Health News:Highlights from The North American Menopause Society 25th Annual Meeting 3Health News:High-Fat, Low-Carb Diet May Help With Tough-to-Treat Epilepsy 2Health News:High-Fat, Low-Carb Diet May Help With Tough-to-Treat Epilepsy 3
... Senior,Services has expanded into the San Joaquin County, California ... Response Company, is proud to announce seniors in San ... Services for outstanding,care. For over a decade, a caring ... sincere concern for the betterment of life that goes ...
... Donor Centers, LENEXA, Kan., Oct. 31 ... provider of ClosedLoop(TM) clinical,systems for blood and medication ... of substantially all of the assets of Integrated,Marketing ... products and,services that enable blood and plasma donation ...
... (NYSE: BSX ) announced today that a jury ... Boston Scientific infringes a patent of,Cordis Corporation, a subsidiary ... Company said it believes the finding of infringement is,in ... overturn it. No damages were determined because the ...
... MEMPHIS, Tenn., Oct. 31 Mrs. Vivian,Berryhill will ... Global Summit,on AIDS and the Church, at Saddleback ... president of the National Coalition of Pastors,Spouses (NCPS), ... whose mission is to raise health awareness in,communities ...
... chiropractic,and five friends of chiropractic were honored with ... State Convention on,October 21, 2007 at the Doubletree ... their chiropractic colleagues and peers., In recognition ... profession in Colorado, the following individuals received,these prestigious ...
... the scientific journal Genome Research ( www.genome.org ) ... domestic cat genome ( Felis catus ). , ... well-documented lineage can be traced back several generations to Sweden, ... that are currently being analyzed using light (two-fold) genome sequence ...
Cached Medicine News:Health News:Announcing Always Best Care Senior Services Expansion Into San Joaquin County, California 2Health News:Mediware Completes Acquisition of Integrated Marketing Solutions 2Health News:Mediware Completes Acquisition of Integrated Marketing Solutions 3Health News:Boston Scientific Announces Verdict in Cordis Litigation 2Health News:Boston Scientific Announces Verdict in Cordis Litigation 3Health News:Head of Pastors' Spouses to Challenge Women at Saddleback's Global Summit on AIDS and the Church 2Health News:Colorado Doctors of Chiropractic Win Awards 2Health News:Domestic cat genome sequenced 2
... Cronin, Inc. is a ... Footwear, Orthopedic Softgoods, and ... Our products are of ... available in the USA ...
... lightweight brace is designed for the ... fractures. The anatomically correct design achieves ... for optimal control of ulnar segments. ... motion is permitted to prevent problems ...
Finger /Thumb Splint has a stay that may be shaped to hold finger or thumb in exact degree of flexion. It also has a contact closure....
... joint or DIP joint flexioncontractures of any degree. ... gel-lining cushions injured fingers so treatment to straighten ... more successful therapy results. Use during the day ... maintain gains in motion. Available in small, medium ...
Medicine Products: